SHUKRA PHARMACEUTICALS L (SHUKRAPHAR) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

SHUKRAPHARUpdated 14 Aug 2026, 17:37

Shukra Pharmaceuticals L

Market Cap

₹1,821Cr.

Current Price

₹41.4

High / Low

₹65.3/17.1

Stock P/E

50.5

Book Value₹2.05
Dividend Yield0.02%
ROCE36.9%
ROE28.9%
Face Value₹1.00

About

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Aug 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days737117520034524531813218712098148
Inventory Days55492112531001692211392519447320
Days Payable2911084007341,16178670230327159414232
Cash Conversion Cycle33554-112-480-717-372-163-32-5880131236
Working Capital Days7582583443794402262785741157404352
ROCE %-1%6%7%6%4%0%1%6%19%44%22%37%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 14 August 2026 at 17:37


Designed & Shipped by Harshit Bansal